Datasheet

生物学的記述

Specificity	ANP32A Antibody [D12M13 detects endogenous levels of total ANP32A protein.
Background	ANP32A, also known as PHAP1 or acidic nuclear phosphoprotein 32 family member A, is a multifunctional member of the ANP32 family that regulates chromatin remodeling, phosphatase activity, apoptosis, and transcriptional control in both nuclear and cytoplasmic compartments. The protein contains an N-terminal leucine-rich repeat (LRR) domain that mediates protein-protein interactions and a highly acidic C-terminal tail enriched in aspartate and glutamate residues that interacts with histones and chromatin-associated factors. ANP32A functions as a component of the inhibitor of histone acetyltransferase (INHAT) complex, where it masks histone tails and suppresses histone acetyltransferase activity, thereby limiting chromatin relaxation and maintaining transcriptional repression at specific gene loci. ANP32A also modulates protein phosphatase 2A (PP2A) signaling through formation of inhibitory complexes involving SET and PP2A holoenzymes, reducing substrate dephosphorylation and sustaining phosphorylation of signaling proteins within MAPK and Akt pathways during stress and survival responses. Through PP2A regulation, ANP32A influences ERK, p38, and Akt signaling dynamics linked to proliferation, apoptosis resistance, and cellular adaptation. The protein additionally recruits HDAC3-containing repressor complexes to target promoters, contributing to histone deacetylation and chromatin condensation in proliferating cells. During apoptosis, ANP32A undergoes relocalization and caspase-3-mediated cleavage, generating fragments that participate in mitochondrial apoptotic signaling through interactions with Apaf-1 and regulation of Bak oligomerization and cytochrome c release. In neuronal systems, ANP32A contributes to PP2A-dependent tau dephosphorylation and maintenance of microtubule stability, linking its activity to neuronal integrity and cytoskeletal regulation. Altered ANP32A expression has been associated with several malignancies including prostate, breast, and pancreatic cancers, where disruption of PP2A regulatory balance and apoptotic signaling contributes to abnormal survival and tumor progression. ANP32A additionally serves as a host factor for influenza A virus polymerase complexes, supporting efficient viral RNA replication within the nucleus, while tissue-specific isoforms display variable phosphatase regulatory activity.

Specificity

ANP32A Antibody [D12M13 detects endogenous levels of total ANP32A protein.

Background

ANP32A, also known as PHAP1 or acidic nuclear phosphoprotein 32 family member A, is a multifunctional member of the ANP32 family that regulates chromatin remodeling, phosphatase activity, apoptosis, and transcriptional control in both nuclear and cytoplasmic compartments. The protein contains an N-terminal leucine-rich repeat (LRR) domain that mediates protein-protein interactions and a highly acidic C-terminal tail enriched in aspartate and glutamate residues that interacts with histones and chromatin-associated factors. ANP32A functions as a component of the inhibitor of histone acetyltransferase (INHAT) complex, where it masks histone tails and suppresses histone acetyltransferase activity, thereby limiting chromatin relaxation and maintaining transcriptional repression at specific gene loci. ANP32A also modulates protein phosphatase 2A (PP2A) signaling through formation of inhibitory complexes involving SET and PP2A holoenzymes, reducing substrate dephosphorylation and sustaining phosphorylation of signaling proteins within MAPK and Akt pathways during stress and survival responses. Through PP2A regulation, ANP32A influences ERK, p38, and Akt signaling dynamics linked to proliferation, apoptosis resistance, and cellular adaptation. The protein additionally recruits HDAC3-containing repressor complexes to target promoters, contributing to histone deacetylation and chromatin condensation in proliferating cells. During apoptosis, ANP32A undergoes relocalization and caspase-3-mediated cleavage, generating fragments that participate in mitochondrial apoptotic signaling through interactions with Apaf-1 and regulation of Bak oligomerization and cytochrome c release. In neuronal systems, ANP32A contributes to PP2A-dependent tau dephosphorylation and maintenance of microtubule stability, linking its activity to neuronal integrity and cytoskeletal regulation. Altered ANP32A expression has been associated with several malignancies including prostate, breast, and pancreatic cancers, where disruption of PP2A regulatory balance and apoptotic signaling contributes to abnormal survival and tumor progression. ANP32A additionally serves as a host factor for influenza A virus polymerase complexes, supporting efficient viral RNA replication within the nucleus, while tissue-specific isoforms display variable phosphatase regulatory activity.

使用情報

Application

WB, IHC, IF

Dilution

WB	IHC	IF
1:2000-1:10000	1:200-1:800	1:200-1:800

Reactivity

Rat, Mouse, Human

Source

Mouse Monoclonal Antibody

MW

29 kDa

Storage Buffer

PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3

Storage
(from the date of receipt)

-20°C (avoid freeze-thaw cycles), 2 years

プロトコール

References

https://pubmed.ncbi.nlm.nih.gov/25156960/
https://pubmed.ncbi.nlm.nih.gov/26918356/

ANP32A Antibody [D12M13]

生物学的記述

使用情報

References

Application Data